“As we said prior, over time, we expect that the reimbursement erosion, which was one of the primary headwinds that we faced in the retail pharmacy business will equal the cost of goods improvement to drive a more sustainable and durable marketplace.”

How to check this claim

Look at: Retail pharmacy segment margin dynamics, specifically whether reimbursement rate erosion (pressure on pharmacy margins from PBM/payor reimbursement rates) is offset by cost of goods sold improvements (drug purchasing cost savings), as discussed in management commentary

It came true if: Management states or discloses that reimbursement pressure has been fully offset by cost of goods improvements, i.e., retail pharmacy gross margin (excluding volume/mix effects) stabilizes or improves rather than continuing to decline

Where: CVS Health quarterly earnings call management commentary and segment results (10-Q/10-K pharmacy segment margin disclosures)

Verify independently

SEC filings for CVS ↗ · Claim quote is verbatim from the 2025Q2 earnings call.